Back to User profile » Dr Richard Monk
Paper published by Dr Richard Monk:
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry
Rahaghi FF, Monk R, Ramakrishnan V, Beiko T, Strange C
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:3193-3199
Published Date: 3 December 2020